Trulieve Cannabis (TSE:TRU) Raised to “Moderate Buy” at Cormark

Trulieve Cannabis (TSE:TRU) was upgraded by Cormark from a “hold” rating to a “moderate buy” rating in a report released on Monday,Zacks.com reports.

Other analysts also recently issued reports about the company. Craig Hallum upgraded Trulieve Cannabis to a “strong-buy” rating in a report on Wednesday, February 26th. Atb Cap Markets upgraded shares of Trulieve Cannabis from a “hold” rating to a “strong-buy” rating in a research note on Monday, December 9th.

Trulieve Cannabis Price Performance

Insider Activity

In other news, Senior Officer Wes Getman acquired 9,500 shares of Trulieve Cannabis stock in a transaction that occurred on Friday, December 13th. The shares were purchased at an average cost of C$7.02 per share, for a total transaction of C$66,702.35.

About Trulieve Cannabis

TransUnion provides risk and information solutions. The company operates in three segments: U.S. Markets, International, and Consumer Interactive. The U.S. Markets segment provides consumer reports, actionable insights, and analytics to businesses. These businesses use its services to acquire new customers; assess consumer ability to pay for services; identify cross-selling opportunities; measure and manage debt portfolio risk; collect debt; verify consumer identities; and mitigate fraud risk.